Tumor Biology

, Volume 36, Issue 4, pp 2343–2349 | Cite as

The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them

  • Huiyu Zhuang
  • Mingzi Tan
  • Juanjuan Liu
  • Xiao Li
  • Jian Gao
  • Zhenhua Hu
  • Lu Deng
  • Liancheng Zhu
  • Bei Lin
Research Article


The main aim of this study was to explore the molecular structural relationship between annexin II (ANXA2) and Lewis y antigen by determining their expression patterns and clinical significance in ovarian epithelial carcinoma. The structural relationship between ANXA2 and Lewis y antigen was examined using immunoprecipitation and confocal laser scanning microscopy in two ovarian caner cell lines ES-2 and CaoV-3. We also constracted the stably transfected cell lines with low ANXA2 gene expression in order to detect the expression level between ANXA2 and Lewis y. ANXA2 and Lewis y were detected in tissues from malignant, borderline, benign, and normal ovarian tissues using immunohistochemical analysis. ANXA2 and Lewis y were present in both two ovarian cancer cells and ANXA2 contained Lewis y antigen. Moreover, expression of Lewis y antigen in ANXA2 from cell after transfection was higher than that before. Our immunohistochemistry data revealed significantly higher positive expression rates of ANXA2 in malignant ovarian tissues, compared to benign tumor and normal tissue, similar to Lewis y antigen levels in ovarian cancer. Notably, tissues displaying marked expression of ANXA2 simultaneously expressed high levels of Lewis y antigen. A linear correlation between the expression patterns of ANXA2 and Lewis y antigen was evident. Consistently, double-labeling immunofluorescence experiments illustrated co-localization of ANXA2 and Lewis y antigen within the same area. In conclusions, ANXA2 contains Lewis y antigen. Our results further demonstrate a close correlation between the expression levels of the two antigens, which are significantly high in ovarian cancer.


Ovarian epithelial carcinoma Annexin II Lewis y antigen Co-immunoprecipitation Immunohistochemistry 



This work was supported by the National Natural Science Foundation of China (Nos. 81172491 and 81101527), Ph.D. Programs Foundation of Ministry of Education of China (Nos. 20112104110016 and 20112104120019), and Shengjing Free Researcher Project (No. 201303).

Conflicts of interest



  1. 1.
    Moriwaki K, Miyoshi E. Fucosylation and gastrointestinal cancer. World J Hepatol. 2010;2:151–61.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Chhieng DC, Rodriguez-Burford C, Talley LI, Sviglin H, Stockard CR, Kleinberg MJ, et al. Expression of cea, tag-72, and lewis-y antigen in primary and metastatic lesions of ovarian carcinoma. Hum Pathol. 2003;34:1016–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Li Q, Liu S, Lin B, Yan L, Wang Y, Wang C, et al. Expression and correlation of lewis y antigen and integrins alpha5 and beta1 in ovarian serous and mucinous carcinoma. Int J Gynecol Cancer : Off J Int Gynecol Cancer Soc. 2010;20:1482–9.Google Scholar
  4. 4.
    Yin BW, Finstad CL, Kitamura K, Federici MG, Welshinger M, Kudryashov V, et al. Serological and immunochemical analysis of lewis y (ley) blood group antigen expression in epithelial ovarian cancer. Int J Cancer J Int du Cancer. 1996;65:406–12.CrossRefGoogle Scholar
  5. 5.
    Liu JJ, Lin B, Hao YY, Li FF, Liu DW, Qi Y, et al. Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway. Oncol Rep. 2010;23:833–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Yan LM, Lin B, Zhu LC, Hao YY, Qi Y, Wang CZ, et al. Enhancement of the adhesive and spreading potentials of ovarian carcinoma rmg-1 cells due to increased expression of integrin alpha5beta1 with the lewis y-structure on transfection of the alpha1,2-fucosyltransferase gene. Biochimie. 2010;92:852–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Gao L, Yan L, Lin B, Gao J, Liang X, Wang Y, et al. Enhancive effects of lewis y antigen on cd44-mediated adhesion and spreading of human ovarian cancer cell line rmg-i. J exp Clin Cancer Res: CR. 2011;30:15.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem. 2006;281:2572–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Orczyk-Pawilowicz M. [The role of fucosylation of glycoconjugates in health and disease]. Postepy higieny i medycyny doswiadczalnej (Online). 2007;61:240–52.Google Scholar
  10. 10.
    Sharma M, Ownbey RT, Sharma MC. Breast cancer cell surface annexin ii induces cell migration and neoangiogenesis via tpa dependent plasmin generation. Exp Mol Pathol. 2010;88:278–86.CrossRefPubMedGoogle Scholar
  11. 11.
    Dai Z, Liu YK, Cui JF, Shen HL, Chen J, Sun RX, et al. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics. 2006;6:5857–67.CrossRefPubMedGoogle Scholar
  12. 12.
    Gu J, Taniguchi N. Potential of n-glycan in cell adhesion and migration as either a positive or negative regulator. Cell Adhes Migr. 2008;2:243–5.CrossRefGoogle Scholar
  13. 13.
    Madjd Z, Parsons T, Watson NF, Spendlove I, Ellis I, Durrant LG. High expression of lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Res: BCR. 2005;7:R780–787.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Arai Y, Nishida M. Differential diagnosis between normal endometrium and endometrial hyperplasia with immunostaining cytology using anti-ley monoclonal antibody. Int J Gynecol Cancer : Off J Int Gynecol Cancer Soc. 2003;13:42–6.CrossRefGoogle Scholar
  15. 15.
    Kim YS, Yuan M, Itzkowitz SH, Sun QB, Kaizu T, Palekar A, et al. Expression of ley and extended ley blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues. Cancer Res. 1986;46:5985–92.PubMedGoogle Scholar
  16. 16.
    Benaud C, Gentil BJ, Assard N, Court M, Garin J, Delphin C, et al. Ahnak interaction with the annexin 2/s100a10 complex regulates cell membrane cytoarchitecture. J Cell Biol. 2004;164:133–44.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Laohavisit A, Davies JM. Annexins. New Phytologist. 2011;189:40–53.CrossRefPubMedGoogle Scholar
  18. 18.
    Bandorowicz-Pikula J, Wos M. Pikula S: [participation of annexins in signal transduction, regulation of plasma membrane structure and membrane repair mechanisms]. Postepy Biochem. 2012;58:135–48.PubMedGoogle Scholar
  19. 19.
    Zhang HJ, Yao DF, Yao M, Huang H, Wu W, Yan MJ, et al. Expression characteristics and diagnostic value of annexin a2 in hepatocellular carcinoma. World J Gastroenterol: WJG. 2012;18:5897–904.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Shetty PK, Thamake SI, Biswas S, Johansson SL, Vishwanatha JK. Reciprocal regulation of annexin a2 and egfr with her-2 in her-2 negative and herceptin-resistant breast cancer. PLoS One. 2012;7:e44299.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Meng Q, Lei T, Zhang M, Zhao J, Zhao XH, Zhang M. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/adm) and parental (pumc-91) human bladder cancer cell lines by proteome analysis. J Cancer Res Clin Oncol. 2013;139:509–19.CrossRefPubMedGoogle Scholar
  22. 22.
    Seckinger A, Meissner T, Moreaux J, Depeweg D, Hillengass J, Hose K, et al. Clinical and prognostic role of annexin a2 in multiple myeloma. Blood. 2012;120:1087–94.CrossRefPubMedGoogle Scholar
  23. 23.
    Liu A, Liu D, Zhao S, Zheng J, Cao D, Zhang H. Up regulation of annexin a2 on murine h22 hepatocarcinoma cells induced by cartilage polysaccharide. Cancer Epidemiol. 2011;35:490–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Zhuang H, Gao J, Hu Z, Liu J, Liu D, Lin B. Co-expression of lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma. PLoS One. 2013;8:e68994.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kirchhoff C. Molecular characterization of epididymal proteins. Rev Reprod. 1998;3:86–95.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Huiyu Zhuang
    • 1
  • Mingzi Tan
    • 1
  • Juanjuan Liu
    • 1
  • Xiao Li
    • 1
  • Jian Gao
    • 1
  • Zhenhua Hu
    • 1
  • Lu Deng
    • 1
  • Liancheng Zhu
    • 1
  • Bei Lin
    • 1
    • 2
  1. 1.Department of Obstetrics and GynecologyShengjing Hospital affiliated to China Medical UniversityShenyangChina
  2. 2.Department of Obstetrics and GynecologyChina Medical University Shengjing HospitalShenyangChina

Personalised recommendations